Trial Information
PET/CT to Identify "Vulnerable" Arterial Plaque
Inclusion Criteria:
- Patients referred for clinical FDG-PET/CT studies
- Patients 50 yr or older
- Patients signed informed consent
Exclusion Criteria:
- Patients unable or unwilling to tolerate the scan until its completion
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Outcome Measure:
the impact of the imaging modality on patient management
Principal Investigator
Ora Israel, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Rambam Health Care Campus
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
plaqueCTIL
NCT ID:
NCT00416065
Start Date:
April 2004
Completion Date:
Related Keywords: